Quick Answer
AVAI BIO, INC. reported Stockholders Equity of -$1.56 million for fiscal year 2025.
AVAI BIO, INC. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | -$1.56M | -6.6% |
| 2024 | -$1.47M | -131.6% |
| 2023 | -$633.3K | -56.1% |
| 2022 | -$405.6K | -23.9% |
| 2021 | -$327.4K | -768.8% |
| 2020 | -$37.7K | +0.0% |
| 2020 | -$37.7K | +24.0% |
| 2019 | -$49.6K | -1621.4% |
| 2018 | $3.3K | — |
| 2017 | $0.00 | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | -$2.79M | -30.9% | -21.5% |
| September 30, 2025 | -$2.30M | -26.7% | -15.5% |
| June 30, 2025 | -$1.99M | +4.5% | -27.3% |
| March 31, 2025 | -$1.56M | -6.6% | +26.8% |
| December 31, 2024 | -$2.14M | -52.4% | -17.6% |
| September 30, 2024 | -$1.82M | -83.1% | +12.9% |
| June 30, 2024 | -$2.08M | -109.8% | -42.1% |
| March 31, 2024 | -$1.47M | -131.6% | -4.7% |
- AVAI BIO, INC. showed a decrease of -6.6% in Stockholders Equity compared to the prior fiscal year.
- The most recent figure is from AVAI BIO, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on July 8, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: